Search Ontology:
ChEBI
hydroxychloroquine
- Term ID
- CHEBI:5801
- Synonyms
-
- (+-)-hydroxychloroquine
- 2-((4-((7-chloro-4-quinolyl)amino)pentyl)ethylamino)ethanol
- 2-(N-(4-(7-chlor-4-chinolylamino)-4-methylbutyl)ethylamino)ethanol
- 2-[{4-[(7-chloroquinolin-4-yl)amino]pentyl}(ethyl)amino]ethanol
- 7-chloro-4-(4-(ethyl(2-hydroxyethyl)amino)-1-methylbutylamino)quinoline
- 7-chloro-4-(4-(N-ethyl-N-beta-hydroxyethylamino)-1-methylbutylamino)quinoline
- 7-chloro-4-[4-(N-ethyl-N-beta-hydroxyethylamino)-1-methylbutylamino]quinoline
- 7-chloro-4-[5-(N-ethyl-N-2-hydroxyethylamino)-2-pentyl]aminoquinoline
- hidroxicloroquina
- hydroxychloroquine
- hydroxychloroquinum
- NSC4375
- oxichlorochine
- oxichloroquine
- Polirreumin
- Definition
- An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
- References
-
- CAS:118-42-3
- DrugBank:DB01611
- Drug_Central:1395
- HMDB:HMDB0015549
- KEGG:C07043
- KEGG:D08050
- LINCS:LSM-5193
- PMCID:PMC7122276
- PMID:23216212
- PMID:23218706
- PMID:23481418
- PMID:23485647
- PMID:23581274
- PMID:23778483
- PMID:23887202
- PMID:23902281
- PMID:32215614
- PMID:32269046
- PMID:32283236
- PMID:32294807
- PMID:32295788
- PMID:32295814
- PMID:32311324
- PMID:32327429
- Patent:US2546658
- Reaxys:253894
- Wikipedia:Hydroxychloroquine
- Ontology
- ChEBI ( EBI )
- Resources
- CTD
Phenotype
Phenotype resulting from hydroxychloroquine
Phenotype where environments contain hydroxychloroquine
Phenotype modified by environments containing hydroxychloroquine
Phenotype affecting hydroxychloroquine
Human Disease Model